These ASX 200 shares could be top buys next week

Brokers are feeling very positive about these ASX 200 shares.

| More on:
Two brokers analysing stocks.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

There are plenty of options to choose from on the ASX 200 index, but which ones could be buys next week?

Two that could be worth considering according to brokers are listed below. Here's why they rate these ASX 200 shares as buys:

Seek Ltd (ASX: SEK)

The first ASX 200 share that has been named as a buy is Seek. It is the online employment classifieds platform giant with operations across 12 countries.

The team at Morgans is positive on the company. This is because it believes Seek will benefit from a number of tailwinds that will support increased reliance on the company's products and services. It said:

Of the classifieds players, we continue to see SEEK as the one with the most relative upside, a view that's based on the sustained listings growth we've seen over the period. The tailwinds that have driven elevated job ads (~210k currently, broadly flat on the robust pcp) and strong FY22 result appear to still remain in place, i.e. subdued migration, candidate scarcity and the drive for greater employee flexibility. With businesses looking to grow headcount in the coming months and job mobility at historically high levels according to the RBA, we see these favourable operating conditions driving increased reliance on SEEK's products.

Morgans currently has an add and $28.40 price target on Seek's shares.

Sonic Healthcare Limited (ASX: SHL)

Another ASX 200 share that is rated highly is Sonic Healthcare. It is a healthcare company offering pathology, diagnostic imaging, and primary care medical services across a network of operations spanning the ANZ, European and North American markets.

Thanks to its strong balance sheet, the team at Citi believe the company could be in a position to continue adding to this network in the near future to support its growth. It commented:

SHL announced a binding agreement to acquire Diagnosticum, a laboratory group in southeast Germany with 15 labs and 25 pathologists. SHL will pay €190m (cash, debt free) / ~A$310m. […] The transaction is in-line with the company's long-term strategy of deploying capital through acquisitions (>40 since FY07). SHL estimates that the top-5 players in Germany only have a 40-50% market share (SHL being #1), leaving room for further consolidation. We rate SHL Buy,

In light of this, Citi has a buy rating and $40.00 price target on its shares.

Motley Fool contributor James Mickleboro has positions in Seek. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Seek and Sonic Healthcare. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A bricklayer peeps over the top of a brick wall he is laying with a level measuring tool on top.
Broker Notes

Are Brickworks shares a buy, hold or sell ahead of earnings season?

Brokers have been weighing property gains, US headwinds, and merger impacts to form a view.

Read more »

A man in his office leans back in his chair with his hands behind his head looking out his window at the city, sitting back and relaxed, confident in his ASX share investments for the long term.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A woman with a mobile phone in her hand looks sceptical with a puzzled expression on her face with an eyebrow raised and pursed lips.
Broker Notes

Buy these 2 ASX consumer stocks in the dip: expert

Can you guess which 2 were named?

Read more »

Miner puts thumbs up in front of gold mine quarry
Gold

Why Macquarie expects this ASX 200 gold stock to surge 55%

Macquarie forecasts a big rebound ahead for this beaten down ASX 200 gold miner.

Read more »

Man smiling at a laptop because of a rising share price.
Broker Notes

4 ASX shares to buy this week: experts

Looking for investment inspiration?

Read more »

Excited couple celebrating success while looking at smartphone.
Broker Notes

Macquarie forecasts 28% upside for this ASX All Ords stock

Let's see why the broker is feeling bullish about this name.

Read more »

A share market analyst looks at his computer screen in front of him showing ASX share price movements
Broker Notes

What's Macquarie focused on this earnings season?

Here's what the broker is saying about next month's results releases.

Read more »

A young man goes over his finances and investment portfolio at home.
Broker Notes

Should you buy Zip shares and sell NextDC shares?

Let's see what one analyst is saying about these popular shares.

Read more »